{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:41:06Z","timestamp":1787002866731,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2021R1A2C1004033"],"award-info":[{"award-number":["NRF-2021R1A2C1004033"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Fund of Biomedical Research Institute, Jeonbuk National University Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by immune-complex deposits and inflammatory cell infiltrations in multiple organs. Approximately half of lupus patients have nephritis. Lymphangiogenesis is the proliferation of lymphatic vessels (LVs), which regulate tissue fluid homeostasis and immune cell trafficking, responding to the tissue environment. In this study, we evaluated the therapeutic effect of SAR131675, a selective VEGFR-3 inhibitor, on the murine lupus nephritis model by regulating inflammation and lymphangiogenesis. We evaluated biopsy-proven lupus nephritis with immunohistochemical staining for D2-40, a marker for human lymphatic endothelial cells. For animal experiments, 7- to 8-week-old male BALB\/c mice were used. For the induction of a lupus-like model, the dorsal skin of mice was shaved and given topical treatment every other day with 100\u2009\u03bcg resiquimod dissolved in 100\u2009\u03bcL acetone during the 8-week treatment. We had renal histology and immunofluorescent study for inflammatory cells and lymphatic vessels. We also had a qRT-PCR and Western blot analysis to evaluate inflammatory cytokines and chemokines, lymphangiogenic factors, and TLR7\/type I IFN response. A human study found that the higher the revised ISN\/RPS LN histopathological classification and modified NIH activity indexes, the more D2-40 (+) lymphatic vessels were expressed in the tubulointerstitial areas. Inhibition of VEGFR-3 by oral SAR131675 treatment decreased the resiquimod-induced glomerular and tubulointerstitial inflammation and attenuated LYVE-1 (+) lymphatic vessel expression in the murine lupus model. Treatment SAR131675 decreased the resiquimod-induced increase of proinflammatory cytokines and chemokines by regulating TLR7\/MyD88\/IFN-\u03b1 expression. This study suggests the therapeutic potential of targeting lymphatic proliferation by VEGFR-3 inhibition in lupus nephritis. Modulation of the lymphatic network may provide a novel approach to treating chronic inflammation and attenuating renal autoimmune response.<\/jats:p>","DOI":"10.1038\/s41420-025-02624-4","type":"journal-article","created":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T13:36:00Z","timestamp":1752327360000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Inhibition of VEGFR-3 by SAR131675 decreases renal inflammation and lymphangiogenesis in the murine lupus nephritis model"],"prefix":"10.1038","volume":"11","author":[{"given":"Tian","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hyun","family":"Yeom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8720-9701","authenticated-orcid":false,"given":"Kyung Pyo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,12]]},"reference":[{"key":"2624_CR1","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1681\/ASN.2013010026","volume":"24","author":"M Lech","year":"2013","unstructured":"Lech M, Anders HJ. The pathogenesis of lupus nephritis. J Am Soc Nephrol. 2013;24:1357\u201366. https:\/\/doi.org\/10.1681\/ASN.2013010026.","journal-title":"J Am Soc Nephrol"},{"key":"2624_CR2","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1056\/NEJMra1100359","volume":"365","author":"GC Tsokos","year":"2011","unstructured":"Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365:2110\u201321. https:\/\/doi.org\/10.1056\/NEJMra1100359.","journal-title":"N Engl J Med"},{"key":"2624_CR3","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.coi.2012.10.004","volume":"24","author":"J Choi","year":"2012","unstructured":"Choi J, Kim ST, Craf J. The pathogenesis of systemic lupus erythematosus-an update. Curr Opin Immunol. 2012;24:651\u20137. https:\/\/doi.org\/10.1016\/j.coi.2012.10.004.","journal-title":"Curr Opin Immunol"},{"key":"2624_CR4","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/art.42375","volume":"75","author":"M Hocaoglu","year":"2023","unstructured":"Hocaoglu M, Valenzuela-Almada MO, Dabit YJ, Osei-Onomah SA, Chevet B, Giblon RE, et al. Incidence, prevalence, and mortality of lupus nephritis: a population-based study over four decades using the lupus midwest network. Arthritis Rheumatol. 2023;75:567\u201373. https:\/\/doi.org\/10.1002\/art.42375.","journal-title":"Arthritis Rheumatol"},{"key":"2624_CR5","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.cell.2010.01.045","volume":"140","author":"T Tammela","year":"2010","unstructured":"Tammela T, Alitalo K. Lymphangiogenesis: Molecular mechanisms and future promise. Cell. 2010;140:460\u201376. https:\/\/doi.org\/10.1016\/j.cell.2010.01.045.","journal-title":"Cell"},{"key":"2624_CR6","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1172\/JCI71607","volume":"124","author":"H Kim","year":"2014","unstructured":"Kim H, Kataru RP, Koh GY. Inflammation-associated lymphangiogenesis: a double-edged sword?. J Clin Invest. 2014;124:936\u201342. https:\/\/doi.org\/10.1172\/JCI71607.","journal-title":"J Clin Invest"},{"key":"2624_CR7","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1172\/JCI74854","volume":"124","author":"D Kerjaschki","year":"2014","unstructured":"Kerjaschki D. The lymphatic vasculature revisited. J Clin Invest. 2014;124:874\u20137. https:\/\/doi.org\/10.1172\/JCI74854.","journal-title":"J Clin Invest"},{"key":"2624_CR8","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1600-6143.2006.01638.x","volume":"7","author":"S Stuht","year":"2007","unstructured":"Stuht S, Gwinner W, Franz I, Schwarz I, Jonigk D, Kreipe H, et al. Lymphatic neoangiogenesis in human renal allografts: results from sequential protocol biopsies. Am J Transpl. 2007;7:377\u201384. https:\/\/doi.org\/10.1111\/j.1600-6143.2006.01638.x.","journal-title":"Am J Transpl"},{"key":"2624_CR9","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1161\/CIRCULATIONAHA.109.910703","volume":"121","author":"AI Nykanen","year":"2010","unstructured":"Nykanen AI, Sandelin H, Krebs R, Keranen MA, Tuuminen R, Karpanen T, et al. Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and antiarteriosclerotic effects in cardiac allografts. Circulation. 2010;121:1413\u201322. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.910703.","journal-title":"Circulation"},{"key":"2624_CR10","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1172\/JCI71611","volume":"124","author":"NH Ruddle","year":"2014","unstructured":"Ruddle NH. Lymphatic vessels and tertiary lymphoid organs. J Clin Invest. 2014;124:953\u20139. https:\/\/doi.org\/10.1172\/JCI71611.","journal-title":"J Clin Invest"},{"key":"2624_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1231315","volume":"14","author":"L Esparcia-Pinedo","year":"2023","unstructured":"Esparcia-Pinedo L, Romero-Laorden NM, Alfranca A. Tertiary lymphoid structures and B lymphocytes: a promising therapeutic strategy to fight cancer. Front Immunol. 2023;14:1231315. https:\/\/doi.org\/10.3389\/fimmu.2023.1231315.","journal-title":"Front Immunol"},{"key":"2624_CR12","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.4049\/jimmunol.0804324","volume":"183","author":"NH Ruddle","year":"2009","unstructured":"Ruddle NH, Akirav EM. Secondary lymphoid organs: responding to genetic and environmental cues in ontogeny and the immune response. J Immunol. 2009;183:2205\u201312. https:\/\/doi.org\/10.4049\/jimmunol.0804324.","journal-title":"J Immunol"},{"key":"2624_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.0105-2896.2009.00861.x","volume":"233","author":"A Manzo","year":"2010","unstructured":"Manzo A, Bombardieri M, Humby F, Pitzalis C. Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage\/remodeling. Immunol Rev. 2010;233:267\u201385. https:\/\/doi.org\/10.1111\/j.0105-2896.2009.00861.x.","journal-title":"Immunol Rev"},{"key":"2624_CR14","doi-asserted-by":"publisher","first-page":"717","DOI":"10.4049\/jimmunol.0903589","volume":"185","author":"O Thaunat","year":"2010","unstructured":"Thaunat O, Patey N, Caligiuri G, Gautreau C, Mamani-Matsuda M, Mekki Y, et al. Chronic rejection triggers the development of an aggressive intragraft immune response through recapitulation of lymphoid organogenesis. J Immunol. 2010;185:717\u201328. https:\/\/doi.org\/10.4049\/jimmunol.0903589.","journal-title":"J Immunol"},{"key":"2624_CR15","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.3389\/fimmu.2017.01830","volume":"8","author":"EJ Colbeck","year":"2017","unstructured":"Colbeck EJ, Ager A, Gallimore A, Jones GW. Tertiary lymphoid structures in cancer: drivers of antitumor immunity, immunosuppression, or bystander sentinels in disease?. Front Immunol. 2017;8:1830. https:\/\/doi.org\/10.3389\/fimmu.2017.01830.","journal-title":"Front Immunol"},{"key":"2624_CR16","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.4049\/jimmunol.1001983","volume":"186","author":"A Chang","year":"2011","unstructured":"Chang A, Henderson SG, Brandt D, Liu N, Guttikonda R, Hsieh C, et al. In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis. J Immunol. 2011;186:1849\u201360. https:\/\/doi.org\/10.4049\/jimmunol.1001983.","journal-title":"J Immunol"},{"key":"2624_CR17","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/acr.20441","volume":"63","author":"C Hsieh","year":"2011","unstructured":"Hsieh C, Chang A, Brandt D, Guttikonda R, Utset TO, Clark MR. Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring. Arthrit Care Res. 2011;63:865\u201374. https:\/\/doi.org\/10.1002\/acr.20441.","journal-title":"Arthrit Care Res"},{"key":"2624_CR18","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/ki.2012.409","volume":"83","author":"LH Wu","year":"2013","unstructured":"Wu LH, Yu F, Tan Y, Qu Z, Chen MH, Wang SX, et al. Inclusion of renal vascular lesions in the 2003 ISN\/RPS system for classifying lupus nephritis improves renal outcome predictions. Kidney Int. 2013;83:715\u201323. https:\/\/doi.org\/10.1038\/ki.2012.409.","journal-title":"Kidney Int"},{"key":"2624_CR19","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/ki.2010.13","volume":"77","author":"F Yu","year":"2010","unstructured":"Yu F, Wu LH, Tan Y, Li LH, Wang CL, Wang WK, et al. Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 International Society of Nephrology and Renal Pathology Society system. Kidney Int. 2010;77:820\u20139. https:\/\/doi.org\/10.1038\/ki.2010.13.","journal-title":"Kidney Int"},{"key":"2624_CR20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/ar3465","volume":"13","author":"S Pathak","year":"2011","unstructured":"Pathak S, Mohan C. Cellular and molecular pathogenesis of systemic lupus erythematosus: lessons from animal models. Arthritis Res Ther. 2011;13:241. https:\/\/doi.org\/10.1186\/ar3465.","journal-title":"Arthritis Res Ther"},{"key":"2624_CR21","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","volume":"93","author":"IM Bajema","year":"2018","unstructured":"Bajema IM, Wilhelmus S, Alpers CE, Bruijn JA, Colvin RB, Cook HT, et al. Revision of the International Society of Nephrology\/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney Int. 2018;93:789\u201396. https:\/\/doi.org\/10.1016\/j.kint.2017.11.023.","journal-title":"Kidney Int"},{"key":"2624_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/modpathol.3800253","volume":"18","author":"WW Choi","year":"2005","unstructured":"Choi WW, Lewis MM, Lawson D, Yin-Goen Q, Birdsong GG, Cotsonis GA, et al. Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression. Mod Pathol. 2005;18:143\u201352. https:\/\/doi.org\/10.1038\/modpathol.3800253.","journal-title":"Mod Pathol"},{"key":"2624_CR23","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1365-2559.2005.02098.x","volume":"46","author":"M Fukunaga","year":"2005","unstructured":"Fukunaga M. Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours. Histopathology. 2005;46:396\u2013402. https:\/\/doi.org\/10.1111\/j.1365-2559.2005.02098.x.","journal-title":"Histopathology"},{"key":"2624_CR24","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1053\/j.ajkd.2019.10.017","volume":"76","author":"SV Parikh","year":"2020","unstructured":"Parikh SV, Almaani S, Brodsky S, Rovin BH. Update on Lupus Nephritis: Core Curriculum 2020. Am J Kidney Dis. 2020;76:265\u201381. https:\/\/doi.org\/10.1053\/j.ajkd.2019.10.017.","journal-title":"Am J Kidney Dis"},{"key":"2624_CR25","doi-asserted-by":"publisher","first-page":"166","DOI":"10.23876\/j.krcp.22.083","volume":"42","author":"SE Choi","year":"2023","unstructured":"Choi SE, Fogo AB, Lim BJ. Histologic evaluation of activity and chronicity of lupus nephritis and its clinical significance. Kidney Res Clin Pr. 2023;42:166\u201373. https:\/\/doi.org\/10.23876\/j.krcp.22.083.","journal-title":"Kidney Res Clin Pr"},{"key":"2624_CR26","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/art.38298","volume":"66","author":"M Yokogawa","year":"2014","unstructured":"Yokogawa M, Takaishi M, Nakajima K, Kamijima R, Fujimoto C, Kataoka S, et al. Epicutaneous application of toll-like receptor 7 agonists leads to systemic autoimmunity in wild-type mice: a new model of systemic Lupus erythematosus. Arthritis Rheumatol. 2014;66:694\u2013706. https:\/\/doi.org\/10.1002\/art.38298.","journal-title":"Arthritis Rheumatol"},{"key":"2624_CR27","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1002\/dvdy.21605","volume":"237","author":"EJ Gordon","year":"2008","unstructured":"Gordon EJ, Gale NW, Harvey NL. Expression of the hyaluronan receptor LYVE-1 is not restricted to the lymphatic vasculature; LYVE-1 is also expressed on embryonic blood vessels. Dev Dyn. 2008;237:1901\u20139. https:\/\/doi.org\/10.1002\/dvdy.21605.","journal-title":"Dev Dyn"},{"key":"2624_CR28","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.2353\/ajpath.2007.060018","volume":"170","author":"K Maruyama","year":"2007","unstructured":"Maruyama K, Asai J, Ii M, Thorne T, Losordo DW, D\u2019Amore PA. Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am J Pathol. 2007;170:1178\u201391. https:\/\/doi.org\/10.2353\/ajpath.2007.060018.","journal-title":"Am J Pathol"},{"key":"2624_CR29","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.3390\/ijms25052853","volume":"25","author":"E Stasi","year":"2024","unstructured":"Stasi E, Sciascia S, Naretto C, Baldovino S, Roccatello D. Lymphatic system and the kidney: from lymphangiogenesis to renal inflammation and fibrosis development. Int J Mol Sci. 2024;25:2853. https:\/\/doi.org\/10.3390\/ijms25052853.","journal-title":"Int J Mol Sci"},{"key":"2624_CR30","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41581-021-00438-y","volume":"17","author":"MD Donnan","year":"2021","unstructured":"Donnan MD, Kenig-Kozlovsky Y, Quaggin SE. The lymphatics in kidney health and disease. Nat Rev Nephrol. 2021;17:655\u201375. https:\/\/doi.org\/10.1038\/s41581-021-00438-y.","journal-title":"Nat Rev Nephrol"},{"key":"2624_CR31","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/BOR.0000000000000777","volume":"33","author":"A Chang","year":"2021","unstructured":"Chang A, Clark MR, Ko K. Cellular aspects of the pathogenesis of lupus nephritis. Curr Opin Rheumatol. 2021;33:197\u2013204. https:\/\/doi.org\/10.1097\/BOR.0000000000000777.","journal-title":"Curr Opin Rheumatol"},{"key":"2624_CR32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/ki.2012.312","volume":"83","author":"AS Lee","year":"2013","unstructured":"Lee AS, Lee JE, Jung YJ, Kim DH, Kang KP, Lee S, et al. Vascular endothelial growth factor-C and -D are involved in lymphangiogenesis in mouse unilateral ureteral obstruction. Kidney Int. 2013;83:50\u201362. https:\/\/doi.org\/10.1038\/ki.2012.312.","journal-title":"Kidney Int"},{"key":"2624_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1436-1","volume":"10","author":"SD Hwang","year":"2019","unstructured":"Hwang SD, Song SH, Kim Y, Lim JH, Kim HY, Kim EN, et al. Inhibition of lymphatic proliferation by the selective VEGFR-3 inhibitor SAR131675 ameliorates diabetic nephropathy in db\/db mice. Cell Death Dis. 2019;10:219. https:\/\/doi.org\/10.1038\/s41419-019-1436-1.","journal-title":"Cell Death Dis"},{"key":"2624_CR34","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/path.4473","volume":"235","author":"MT Nihei","year":"2015","unstructured":"Nihei MT, Okazaki T, Ebihara S, Kobayashi M, Niu K, Gui P, et al. Chronic inflammation, lymphangiogenesis, and effect of an anti-VEGFR therapy in a mouse model and in human patients with aspiration pneumonia. J Pathol. 2015;235:632\u201345. https:\/\/doi.org\/10.1002\/path.4473.","journal-title":"J Pathol"},{"key":"2624_CR35","doi-asserted-by":"publisher","first-page":"1204777","DOI":"10.3389\/fimmu.2023.1204777","volume":"14","author":"M Wang","year":"2023","unstructured":"Wang M, Rajkumar S, Lai Y, Liu X, He J, Ishikawa T, et al. Tertiary lymphoid structures as local perpetuators of organ-specific immune injury: implication for lupus nephritis. Front Immunol. 2023;14:1204777. https:\/\/doi.org\/10.3389\/fimmu.2023.1204777.","journal-title":"Front Immunol"},{"key":"2624_CR36","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1016\/j.ajpath.2020.07.015","volume":"190","author":"SE Dorraji","year":"2020","unstructured":"Dorraji SE, Kanapathippillai P, Hovd AK, Stenersrod MR, Horvei KD, Ursvik A, et al. Kidney tertiary lymphoid structures in lupus nephritis develop into large interconnected networks and resemble lymph nodes in gene signature. Am J Pathol. 2020;190:2203\u201325. https:\/\/doi.org\/10.1016\/j.ajpath.2020.07.015.","journal-title":"Am J Pathol"},{"key":"2624_CR37","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/sj.ki.5002734","volume":"73","author":"S Segerer","year":"2008","unstructured":"Segerer S, Schlondorff D. B cells and tertiary lymphoid organs in renal inflammation. Kidney Int. 2008;73:533\u20137. https:\/\/doi.org\/10.1038\/sj.ki.5002734.","journal-title":"Kidney Int"},{"key":"2624_CR38","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.3389\/fimmu.2019.02938","volume":"10","author":"S Luo","year":"2019","unstructured":"Luo S, Zhu R, Yu T, Fan H, Hu Y, Mohanta SK, et al. Chronic inflammation: a common promoter in tertiary lymphoid organ neogenesis. Front Immunol. 2019;10:2938. https:\/\/doi.org\/10.3389\/fimmu.2019.02938.","journal-title":"Front Immunol"},{"key":"2624_CR39","doi-asserted-by":"publisher","first-page":"271","DOI":"10.4110\/in.2016.16.5.271","volume":"16","author":"F Jing","year":"2016","unstructured":"Jing F, Choi EY. Potential of cells and cytokines\/chemokines to regulate tertiary lymphoid structures in human diseases. Immune Netw. 2016;16:271\u201380. https:\/\/doi.org\/10.4110\/in.2016.16.5.271.","journal-title":"Immune Netw"},{"key":"2624_CR40","doi-asserted-by":"publisher","first-page":"5459","DOI":"10.4049\/jimmunol.1002795","volume":"192","author":"MK Crow","year":"2014","unstructured":"Crow MK. Type I interferon in the pathogenesis of lupus. J Immunol. 2014;192:5459\u201368. https:\/\/doi.org\/10.4049\/jimmunol.1002795.","journal-title":"J Immunol"},{"key":"2624_CR41","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nri3581","volume":"14","author":"LB Ivashkiv","year":"2014","unstructured":"Ivashkiv LB, Donlin LT. Regulation of type I interferon responses. Nat Rev Immunol. 2014;14:36\u201349. https:\/\/doi.org\/10.1038\/nri3581.","journal-title":"Nat Rev Immunol"},{"key":"2624_CR42","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1158\/1535-7163.MCT-11-0866-T","volume":"11","author":"A Alam","year":"2012","unstructured":"Alam A, Blanc I, Gueguen-Dorbes G, Duclos O, Bonnin J, Barron P, et al. SAR131675, a potent and selective VEGFR-3-TK inhibitor with antilymphangiogenic, antitumoral, and antimetastatic activities. Mol Cancer Ther. 2012;11:1637\u201349. https:\/\/doi.org\/10.1158\/1535-7163.MCT-11-0866-T.","journal-title":"Mol Cancer Ther"},{"key":"2624_CR43","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.3892\/ijmm.2013.1508","volume":"32","author":"D Kim","year":"2013","unstructured":"Kim D, Lee JE, Jung YJ, Lee SA, Lee S, Park SK, et al. Metformin decreases high-fat diet-induced renal injury by regulating the expression of adipokines and the renal AMP-activated protein kinase\/acetyl-CoA carboxylase pathway in mice. Int J Mol Med. 2013;32:1293\u2013302. https:\/\/doi.org\/10.3892\/ijmm.2013.1508.","journal-title":"Int J Mol Med"},{"key":"2624_CR44","doi-asserted-by":"publisher","first-page":"6481","DOI":"10.4049\/jimmunol.173.10.6481","volume":"173","author":"XK Zhang","year":"2004","unstructured":"Zhang XK, Gallant S, Molano I, Moussa OM, Ruiz P, Spyropoulos DD, et al. Decreased expression of the Ets family transcription factor Fli-1 markedly prolongs survival and significantly reduces renal disease in MRL\/lpr mice. J Immunol. 2004;173:6481\u20139. https:\/\/doi.org\/10.4049\/jimmunol.173.10.6481.","journal-title":"J Immunol"},{"key":"2624_CR45","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.3390\/cells11091477","volume":"11","author":"J Jin","year":"2022","unstructured":"Jin J, Li W, Wang T, Park BH, Park SK, Kang KP. Loss of Proximal Tubular Sirtuin 6 aggravates unilateral ureteral obstruction-induced tubulointerstitial inflammation and fibrosis by regulation of beta-Catenin acetylation. Cells. 2022;11:1477. https:\/\/doi.org\/10.3390\/cells11091477.","journal-title":"Cells"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02624-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02624-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02624-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T13:36:00Z","timestamp":1752327360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02624-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,12]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2624"],"URL":"https:\/\/doi.org\/10.1038\/s41420-025-02624-4","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,12]]},"assertion":[{"value":"14 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The human study was reviewed and approved by the Institutional Review Board of Jeonbuk National University Hospital (CUH-2020-07-032-004). The animal study was reviewed and approved by the Institutional Animal Care and Use Committee of Jeonbuk National University Hospital (cuh-IACUC-2018-18). The authors have no competing interests to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"320"}}